1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Lequin, O. Thuring, H. Robin, M. Lallemand, J.-Y. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking IX Eur.J.Biochem. EJBCAI 0262 0014-2956 250 712 726 10.1111/j.1432-1033.1997.00712.x 9461294 Three-dimensional solution structure of human angiogenin determined by 1H,15N-NMR spectroscopy--characterization of histidine protonation states and pKa values. 1997 10.2210/pdb1awz/pdb pdb_00001awz 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 PANCREATIC RIBONUCLEASE SUPERFAMILY 14169.036 ANGIOGENIN 3.1.27.- 1 man polymer no no QDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTT CKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP QDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAICENKNGNPHRENLRISKSSFQVTT CKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo PLASMA Escherichia Escherichia coli sample 9606 Homo sapiens 37762 Escherichia coli B B PLASMID PXL694 database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1998-02-25 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1997-10-07 REL LEAST RESTRAINT VIOLATION 30 30 3D NOESY-HSQC TOCSY-HMQC HNHA 2D NOESY 150 mM 5.0 1 atm 313 K CHARMM22 PARAMETER FILE RMS DEVIATION FROM EXPERIMENTAL DATA: NOE (A) : 0.0179 DIHEDRAL ANGLES (DEGREES) : 0.99 DISTANCE GEOMETRY, SIMULATED ANNEALING BRUNGER refinement X-PLOR 3.1 structure solution DIANA structure solution X-PLOR 600 Bruker AMX600 GLN 1 n 1 GLN 1 A ASP 2 n 2 ASP 2 A ASN 3 n 3 ASN 3 A SER 4 n 4 SER 4 A ARG 5 n 5 ARG 5 A TYR 6 n 6 TYR 6 A THR 7 n 7 THR 7 A HIS 8 n 8 HIS 8 A PHE 9 n 9 PHE 9 A LEU 10 n 10 LEU 10 A THR 11 n 11 THR 11 A GLN 12 n 12 GLN 12 A HIS 13 n 13 HIS 13 A TYR 14 n 14 TYR 14 A ASP 15 n 15 ASP 15 A ALA 16 n 16 ALA 16 A LYS 17 n 17 LYS 17 A PRO 18 n 18 PRO 18 A GLN 19 n 19 GLN 19 A GLY 20 n 20 GLY 20 A ARG 21 n 21 ARG 21 A ASP 22 n 22 ASP 22 A ASP 23 n 23 ASP 23 A ARG 24 n 24 ARG 24 A TYR 25 n 25 TYR 25 A CYS 26 n 26 CYS 26 A GLU 27 n 27 GLU 27 A SER 28 n 28 SER 28 A ILE 29 n 29 ILE 29 A MET 30 n 30 MET 30 A ARG 31 n 31 ARG 31 A ARG 32 n 32 ARG 32 A ARG 33 n 33 ARG 33 A GLY 34 n 34 GLY 34 A LEU 35 n 35 LEU 35 A THR 36 n 36 THR 36 A SER 37 n 37 SER 37 A PRO 38 n 38 PRO 38 A CYS 39 n 39 CYS 39 A LYS 40 n 40 LYS 40 A ASP 41 n 41 ASP 41 A ILE 42 n 42 ILE 42 A ASN 43 n 43 ASN 43 A THR 44 n 44 THR 44 A PHE 45 n 45 PHE 45 A ILE 46 n 46 ILE 46 A HIS 47 n 47 HIS 47 A GLY 48 n 48 GLY 48 A ASN 49 n 49 ASN 49 A LYS 50 n 50 LYS 50 A ARG 51 n 51 ARG 51 A SER 52 n 52 SER 52 A ILE 53 n 53 ILE 53 A LYS 54 n 54 LYS 54 A ALA 55 n 55 ALA 55 A ILE 56 n 56 ILE 56 A CYS 57 n 57 CYS 57 A GLU 58 n 58 GLU 58 A ASN 59 n 59 ASN 59 A LYS 60 n 60 LYS 60 A ASN 61 n 61 ASN 61 A GLY 62 n 62 GLY 62 A ASN 63 n 63 ASN 63 A PRO 64 n 64 PRO 64 A HIS 65 n 65 HIS 65 A ARG 66 n 66 ARG 66 A GLU 67 n 67 GLU 67 A ASN 68 n 68 ASN 68 A LEU 69 n 69 LEU 69 A ARG 70 n 70 ARG 70 A ILE 71 n 71 ILE 71 A SER 72 n 72 SER 72 A LYS 73 n 73 LYS 73 A SER 74 n 74 SER 74 A SER 75 n 75 SER 75 A PHE 76 n 76 PHE 76 A GLN 77 n 77 GLN 77 A VAL 78 n 78 VAL 78 A THR 79 n 79 THR 79 A THR 80 n 80 THR 80 A CYS 81 n 81 CYS 81 A LYS 82 n 82 LYS 82 A LEU 83 n 83 LEU 83 A HIS 84 n 84 HIS 84 A GLY 85 n 85 GLY 85 A GLY 86 n 86 GLY 86 A SER 87 n 87 SER 87 A PRO 88 n 88 PRO 88 A TRP 89 n 89 TRP 89 A PRO 90 n 90 PRO 90 A PRO 91 n 91 PRO 91 A CYS 92 n 92 CYS 92 A GLN 93 n 93 GLN 93 A TYR 94 n 94 TYR 94 A ARG 95 n 95 ARG 95 A ALA 96 n 96 ALA 96 A THR 97 n 97 THR 97 A ALA 98 n 98 ALA 98 A GLY 99 n 99 GLY 99 A PHE 100 n 100 PHE 100 A ARG 101 n 101 ARG 101 A ASN 102 n 102 ASN 102 A VAL 103 n 103 VAL 103 A VAL 104 n 104 VAL 104 A VAL 105 n 105 VAL 105 A ALA 106 n 106 ALA 106 A CYS 107 n 107 CYS 107 A GLU 108 n 108 GLU 108 A ASN 109 n 109 ASN 109 A GLY 110 n 110 GLY 110 A LEU 111 n 111 LEU 111 A PRO 112 n 112 PRO 112 A VAL 113 n 113 VAL 113 A HIS 114 n 114 HIS 114 A LEU 115 n 115 LEU 115 A ASP 116 n 116 ASP 116 A GLN 117 n 117 GLN 117 A SER 118 n 118 SER 118 A ILE 119 n 119 ILE 119 A PHE 120 n 120 PHE 120 A ARG 121 n 121 ARG 121 A ARG 122 n 122 ARG 122 A PRO 123 n 123 PRO 123 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O ASN 43 A O ASN 43 A N CYS 81 A N CYS 81 A O PHE 76 A O PHE 76 A N ARG 101 A N ARG 101 A O ASN 63 A O ASN 63 A N ILE 71 A N ILE 71 A O ARG 70 A O ARG 70 A N VAL 105 A N VAL 105 A O ALA 106 A O ALA 106 A N HIS 114 A N HIS 114 6 A A H H ASN LYS 59 60 1.17 20 A A H H LYS SER 73 74 1.34 1 A TYR 6 0.087 SIDE CHAIN 6 A TYR 6 0.076 SIDE CHAIN 7 A TYR 6 0.088 SIDE CHAIN 8 A TYR 6 0.071 SIDE CHAIN 9 A TYR 6 0.069 SIDE CHAIN 10 A TYR 6 0.067 SIDE CHAIN 12 A TYR 6 0.066 SIDE CHAIN 13 A TYR 6 0.079 SIDE CHAIN 14 A TYR 6 0.114 SIDE CHAIN 15 A TYR 6 0.102 SIDE CHAIN 16 A TYR 6 0.100 SIDE CHAIN 18 A TYR 6 0.090 SIDE CHAIN 18 A TYR 94 0.074 SIDE CHAIN 21 A TYR 6 0.064 SIDE CHAIN 23 A TYR 6 0.078 SIDE CHAIN 25 A TYR 6 0.070 SIDE CHAIN 26 A TYR 6 0.095 SIDE CHAIN 27 A TYR 6 0.075 SIDE CHAIN 28 A TYR 6 0.067 SIDE CHAIN 30 A TYR 6 0.081 SIDE CHAIN 1 -5.00 0.60 121.00 116.00 A A A CB CG CD2 TYR TYR TYR 6 6 6 N 1 -4.40 0.60 121.00 116.60 A A A CB CG CD2 TYR TYR TYR 14 14 14 N 2 -11.50 1.90 110.20 98.70 A A A CB CA C LEU LEU LEU 10 10 10 N 3 -3.64 0.60 121.00 117.36 A A A CB CG CD1 TYR TYR TYR 6 6 6 N 3 -12.59 1.90 110.20 97.61 A A A CB CA C LEU LEU LEU 10 10 10 N 3 4.56 0.70 120.80 125.36 A A A CB CG CD1 PHE PHE PHE 120 120 120 N 4 -3.81 0.60 121.00 117.19 A A A CB CG CD2 TYR TYR TYR 6 6 6 N 4 10.70 1.70 111.00 121.70 A A A CB CG CD1 LEU LEU LEU 115 115 115 N 5 -4.55 0.60 121.00 116.45 A A A CB CG CD1 TYR TYR TYR 6 6 6 N 5 -6.75 0.60 121.00 114.25 A A A CB CG CD2 TYR TYR TYR 14 14 14 N 5 4.68 0.60 121.00 125.68 A A A CB CG CD1 TYR TYR TYR 14 14 14 N 6 -5.73 0.60 121.00 115.27 A A A CB CG CD2 TYR TYR TYR 6 6 6 N 6 -3.84 0.60 121.00 117.16 A A A CB CG CD2 TYR TYR TYR 14 14 14 N 6 -9.91 1.60 100.20 90.29 A A A CG SD CE MET MET MET 30 30 30 N 7 -4.90 0.60 121.00 116.10 A A A CB CG CD2 TYR TYR TYR 6 6 6 N 8 -5.51 0.60 121.00 115.49 A A A CB CG CD2 TYR TYR TYR 14 14 14 N 8 4.43 0.60 121.00 125.43 A A A CB CG CD1 TYR TYR TYR 14 14 14 N 9 -3.90 0.60 121.00 117.10 A A A CB CG CD2 TYR TYR TYR 6 6 6 N 9 -4.21 0.60 121.00 116.79 A A A CB CG CD2 TYR TYR TYR 14 14 14 N 10 -4.57 0.60 121.00 116.43 A A A CB CG CD2 TYR TYR TYR 14 14 14 N 11 -4.44 0.60 121.00 116.56 A A A CB CG CD1 TYR TYR TYR 6 6 6 N 11 11.76 1.90 110.20 121.96 A A A CB CA C LEU LEU LEU 10 10 10 N 12 -4.33 0.60 121.00 116.67 A A A CB CG CD2 TYR TYR TYR 14 14 14 N 12 11.04 1.70 111.00 122.04 A A A CB CG CD1 LEU LEU LEU 115 115 115 N 12 -4.23 0.70 120.80 116.57 A A A CB CG CD1 PHE PHE PHE 120 120 120 N 13 11.80 1.90 110.20 122.00 A A A CB CA C LEU LEU LEU 10 10 10 N 13 -4.18 0.60 121.00 116.82 A A A CB CG CD2 TYR TYR TYR 14 14 14 N 14 -5.07 0.60 121.00 115.93 A A A CB CG CD2 TYR TYR TYR 6 6 6 N 15 11.92 1.90 110.20 122.12 A A A CB CA C LEU LEU LEU 10 10 10 N 16 -4.67 0.60 121.00 116.33 A A A CB CG CD2 TYR TYR TYR 6 6 6 N 16 -4.55 0.60 121.00 116.45 A A A CB CG CD2 TYR TYR TYR 14 14 14 N 17 11.59 1.90 110.20 121.79 A A A CB CA C LEU LEU LEU 10 10 10 N 17 -3.76 0.60 121.00 117.24 A A A CB CG CD1 TYR TYR TYR 14 14 14 N 18 -6.87 0.60 121.00 114.13 A A A CB CG CD2 TYR TYR TYR 6 6 6 N 18 5.15 0.60 121.00 126.15 A A A CB CG CD1 TYR TYR TYR 6 6 6 N 18 -3.92 0.60 121.00 117.08 A A A CB CG CD2 TYR TYR TYR 14 14 14 N 19 -4.12 0.60 121.00 116.88 A A A CB CG CD1 TYR TYR TYR 6 6 6 N 19 4.53 0.70 120.80 125.33 A A A CB CG CD1 PHE PHE PHE 120 120 120 N 20 -5.34 0.60 121.00 115.66 A A A CB CG CD1 TYR TYR TYR 6 6 6 N 20 -4.75 0.60 121.00 116.25 A A A CB CG CD2 TYR TYR TYR 14 14 14 N 20 11.11 1.70 111.00 122.11 A A A CB CG CD1 LEU LEU LEU 115 115 115 N 22 -5.26 0.60 121.00 115.74 A A A CB CG CD2 TYR TYR TYR 6 6 6 N 22 -5.10 0.70 120.80 115.70 A A A CB CG CD2 PHE PHE PHE 120 120 120 N 22 5.83 0.70 120.80 126.63 A A A CB CG CD1 PHE PHE PHE 120 120 120 N 23 -7.21 0.60 121.00 113.79 A A A CB CG CD2 TYR TYR TYR 6 6 6 N 23 5.95 0.60 121.00 126.95 A A A CB CG CD1 TYR TYR TYR 6 6 6 N 23 -4.23 0.70 120.80 116.57 A A A CB CG CD2 PHE PHE PHE 120 120 120 N 23 4.67 0.70 120.80 125.47 A A A CB CG CD1 PHE PHE PHE 120 120 120 N 24 5.13 0.60 121.00 126.13 A A A CB CG CD2 TYR TYR TYR 6 6 6 N 24 -6.81 0.60 121.00 114.19 A A A CB CG CD1 TYR TYR TYR 6 6 6 N 25 -3.84 0.60 121.00 117.16 A A A CB CG CD2 TYR TYR TYR 14 14 14 N 26 -4.95 0.60 121.00 116.05 A A A CB CG CD2 TYR TYR TYR 14 14 14 N 27 -4.69 0.60 121.00 116.31 A A A CB CG CD2 TYR TYR TYR 6 6 6 N 28 -4.68 0.60 121.00 116.32 A A A CB CG CD2 TYR TYR TYR 6 6 6 N 28 11.14 1.70 111.00 122.14 A A A CB CG CD1 LEU LEU LEU 115 115 115 N 29 5.59 0.60 121.00 126.59 A A A CB CG CD2 TYR TYR TYR 6 6 6 N 29 -7.37 0.60 121.00 113.63 A A A CB CG CD1 TYR TYR TYR 6 6 6 N 29 10.20 1.70 111.00 121.20 A A A CB CG CD1 LEU LEU LEU 115 115 115 N 30 -5.82 0.60 121.00 115.18 A A A CB CG CD2 TYR TYR TYR 6 6 6 N 30 16.95 2.20 113.40 130.35 A A A CA CB CG GLN GLN GLN 77 77 77 N 1 A ASP 2 59.34 71.83 1 A ASN 3 93.15 -28.84 1 A ARG 21 -106.84 73.46 1 A ARG 66 46.31 -109.59 1 A GLU 67 -107.33 77.47 1 A GLN 117 -100.86 41.84 1 A PHE 120 -105.06 43.40 2 A ASN 3 109.36 -26.04 2 A GLN 19 -74.64 -74.99 2 A ARG 21 -118.16 72.56 2 A LYS 60 -159.77 -49.08 2 A ASN 61 -144.34 47.24 2 A ARG 66 65.66 -108.72 2 A SER 74 -109.54 74.02 3 A ASP 2 -102.74 68.01 3 A HIS 13 -127.29 -62.94 3 A ARG 21 -109.53 68.28 3 A ARG 66 60.50 -109.81 3 A GLN 117 -114.20 59.53 4 A ASN 3 111.67 -35.32 4 A GLN 19 -70.10 -76.65 4 A ARG 21 -112.63 74.47 4 A ARG 66 65.51 -102.49 4 A GLN 117 -106.59 51.04 5 A ASN 3 81.71 5.78 5 A ARG 66 66.29 -103.21 5 A GLU 67 -163.36 113.75 5 A HIS 84 -142.10 46.85 5 A PHE 100 -162.28 101.61 5 A GLN 117 -96.18 37.44 6 A ASP 2 -116.50 59.99 6 A GLN 19 -73.21 -73.05 6 A ARG 21 -115.16 72.81 6 A ASN 59 -159.88 -3.46 6 A ARG 66 66.39 -103.59 6 A ASN 68 90.93 -12.70 6 A ASN 109 31.95 68.55 7 A ASP 2 -108.31 60.69 7 A GLN 19 -70.08 -77.97 7 A ARG 21 -110.15 74.67 7 A LYS 60 -141.06 -46.51 7 A ARG 66 70.81 -103.91 7 A SER 87 -163.51 110.74 7 A GLN 117 -106.06 41.06 8 A HIS 13 -123.64 -55.59 8 A ARG 21 -109.38 75.53 8 A ARG 66 69.85 -97.13 8 A GLN 117 -105.41 42.11 9 A ASP 2 -111.34 62.96 9 A ASN 61 73.64 36.14 9 A ARG 66 49.47 -107.33 9 A GLU 67 -103.74 77.53 9 A GLN 117 -101.30 41.76 10 A ARG 21 -112.03 74.40 10 A GLU 58 -106.58 53.12 10 A ASN 59 79.44 -35.97 10 A ASN 61 26.96 55.70 10 A PHE 120 -105.29 47.88 10 A ARG 121 -128.37 -53.37 11 A ASP 2 -115.01 53.17 11 A ASP 41 -63.50 -74.38 11 A CYS 57 -99.64 42.93 11 A LYS 60 -133.06 -35.39 11 A ARG 66 72.12 -101.53 11 A PHE 100 -163.53 106.25 12 A ASP 2 71.33 64.72 12 A ASN 3 77.15 -3.81 12 A GLN 19 -74.86 -71.54 12 A ASN 59 56.25 -87.51 12 A ARG 66 66.68 -111.44 13 A GLN 19 -73.30 -70.19 13 A ARG 21 -116.10 72.57 13 A ARG 66 61.84 -96.67 13 A GLN 117 -103.84 44.28 14 A ASN 3 80.83 2.61 14 A CYS 57 -98.80 34.88 14 A ASN 59 26.23 46.35 14 A ARG 66 81.56 -100.31 14 A GLU 67 -105.34 78.03 14 A GLN 117 -99.96 43.16 14 A PHE 120 -109.94 48.47 15 A ASP 2 -114.61 53.68 15 A ARG 21 -113.30 72.91 15 A ARG 66 65.76 -99.49 15 A GLU 67 -101.42 72.39 15 A PHE 100 -162.38 108.95 15 A PHE 120 -106.97 54.26 15 A ARG 121 62.57 77.69 16 A ASP 2 -110.77 62.60 16 A GLN 19 -75.16 -71.39 16 A ARG 21 -114.68 70.61 16 A ARG 66 66.46 -107.20 16 A SER 74 -106.37 77.26 16 A LEU 115 -170.26 132.88 16 A ARG 121 -91.42 -66.91 17 A ARG 66 63.46 -105.20 17 A PHE 100 -160.62 107.97 17 A GLN 117 -102.08 40.26 18 A ASP 2 -114.02 61.86 18 A GLN 19 -73.25 -79.77 18 A ARG 66 67.94 -100.26 18 A GLU 67 -162.57 108.80 18 A ASN 68 86.71 -6.66 18 A SER 74 -103.03 79.78 18 A GLN 117 -105.16 42.09 18 A PHE 120 -105.61 41.45 19 A GLN 19 -75.78 -73.87 19 A LEU 35 -143.16 23.35 19 A GLU 58 -102.07 57.31 19 A ASN 59 34.81 65.48 19 A LYS 60 -131.94 -58.76 19 A ARG 66 69.49 -101.28 19 A GLU 67 -105.96 77.21 19 A SER 74 -105.39 79.55 19 A ARG 121 -84.30 -73.61 20 A ASN 3 82.65 6.25 20 A GLN 19 -70.87 -77.65 20 A ARG 21 -118.29 72.29 20 A CYS 57 -103.43 44.34 20 A ARG 66 64.59 -102.65 20 A LYS 73 -148.68 -0.08 20 A GLN 117 -110.56 51.24 21 A ASP 2 66.64 83.10 21 A ASN 3 101.14 -32.83 21 A GLN 12 -67.82 -70.33 21 A ARG 21 -114.60 66.43 21 A LYS 60 -130.73 -47.52 21 A ASN 61 -143.99 58.55 21 A ARG 66 65.20 -107.39 22 A ARG 66 62.21 156.56 22 A SER 74 -106.28 78.86 22 A PHE 120 -103.00 52.98 23 A LYS 60 -160.14 -57.74 23 A ARG 66 65.54 -102.26 23 A PHE 120 -105.97 56.80 24 A ASP 2 -118.36 51.53 24 A ARG 66 62.11 -103.26 24 A GLN 117 -96.80 36.89 25 A ASP 2 61.36 65.79 25 A ASN 3 81.36 -6.71 25 A ARG 21 -115.87 73.64 25 A GLU 58 -95.74 51.26 25 A ASN 61 14.52 56.54 25 A ARG 66 63.42 -108.61 25 A ASN 109 75.94 -12.00 25 A GLN 117 -100.07 40.19 25 A PHE 120 -106.12 40.10 26 A ASP 2 75.15 78.32 26 A ASN 3 79.21 -2.43 26 A ASN 61 -113.71 51.20 26 A GLU 67 -104.24 75.36 26 A PHE 120 -97.48 37.79 26 A ARG 121 61.26 67.39 27 A ASP 2 -117.26 55.75 27 A ASN 61 84.95 -8.44 27 A ARG 66 53.82 152.27 27 A ASN 68 83.89 1.45 27 A GLN 117 -115.65 56.71 28 A GLN 19 -72.59 -73.36 28 A ARG 21 -111.80 75.97 28 A ASN 59 73.33 -136.90 28 A ARG 66 64.66 -107.01 28 A GLN 117 -108.84 52.05 29 A ASN 3 84.88 11.20 29 A GLN 19 -72.87 -70.53 29 A ARG 21 -116.66 73.62 29 A ARG 66 62.08 -106.45 29 A VAL 113 -147.40 -27.14 29 A GLN 117 -103.94 45.67 30 A ASP 2 -108.55 58.77 30 A ARG 21 -118.92 55.03 30 A ASN 59 32.10 47.58 30 A ASN 61 -118.55 64.71 30 A ARG 66 61.12 157.62 30 A GLN 117 -101.88 40.77 30 A PHE 120 -103.43 43.47 30 A ARG 121 -153.34 -50.03 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 3D SOLUTION STRUCTURE OF HUMAN ANGIOGENIN DETERMINED BY 1H, 15N NMR SPECTROSCOPY, 30 STRUCTURES 1 Y N A SER 4 A SER 4 HELX_P A GLN 12 A GLN 12 1 1 9 A ASP 23 A ASP 23 HELX_P A ARG 33 A ARG 33 1 2 11 A LYS 50 A LYS 50 HELX_P A ILE 56 A ILE 56 1 3 7 disulf 2.001 A CYS 26 A SG CYS 26 1_555 A CYS 81 A SG CYS 81 1_555 disulf 2.018 A CYS 39 A SG CYS 39 1_555 A CYS 92 A SG CYS 92 1_555 disulf 2.021 A CYS 57 A SG CYS 57 1_555 A CYS 107 A SG CYS 107 1_555 HYDROLASE HYDROLASE, ENDORIBONUCLEASE, ANGIOGENESIS A SER 37 A SER 37 1 A PRO 38 A PRO 38 -18.48 A PRO 90 A PRO 90 1 A PRO 91 A PRO 91 15.85 A SER 37 A SER 37 2 A PRO 38 A PRO 38 -20.25 A PRO 90 A PRO 90 2 A PRO 91 A PRO 91 -1.76 A SER 37 A SER 37 3 A PRO 38 A PRO 38 -21.87 A PRO 90 A PRO 90 3 A PRO 91 A PRO 91 7.37 A SER 37 A SER 37 4 A PRO 38 A PRO 38 -22.02 A PRO 90 A PRO 90 4 A PRO 91 A PRO 91 9.41 A SER 37 A SER 37 5 A PRO 38 A PRO 38 -20.63 A PRO 90 A PRO 90 5 A PRO 91 A PRO 91 1.88 A SER 37 A SER 37 6 A PRO 38 A PRO 38 -24.60 A PRO 90 A PRO 90 6 A PRO 91 A PRO 91 10.81 A SER 37 A SER 37 7 A PRO 38 A PRO 38 -22.45 A PRO 90 A PRO 90 7 A PRO 91 A PRO 91 -4.44 A SER 37 A SER 37 8 A PRO 38 A PRO 38 -22.19 A PRO 90 A PRO 90 8 A PRO 91 A PRO 91 12.33 A SER 37 A SER 37 9 A PRO 38 A PRO 38 -27.48 A PRO 90 A PRO 90 9 A PRO 91 A PRO 91 5.47 A SER 37 A SER 37 10 A PRO 38 A PRO 38 -19.22 A PRO 90 A PRO 90 10 A PRO 91 A PRO 91 19.08 A SER 37 A SER 37 11 A PRO 38 A PRO 38 -24.78 A PRO 90 A PRO 90 11 A PRO 91 A PRO 91 10.92 A SER 37 A SER 37 12 A PRO 38 A PRO 38 -23.72 A PRO 90 A PRO 90 12 A PRO 91 A PRO 91 9.80 A SER 37 A SER 37 13 A PRO 38 A PRO 38 -19.75 A PRO 90 A PRO 90 13 A PRO 91 A PRO 91 3.11 A SER 37 A SER 37 14 A PRO 38 A PRO 38 -16.15 A PRO 90 A PRO 90 14 A PRO 91 A PRO 91 7.88 A SER 37 A SER 37 15 A PRO 38 A PRO 38 -22.37 A PRO 90 A PRO 90 15 A PRO 91 A PRO 91 13.11 A SER 37 A SER 37 16 A PRO 38 A PRO 38 -20.92 A PRO 90 A PRO 90 16 A PRO 91 A PRO 91 4.11 A SER 37 A SER 37 17 A PRO 38 A PRO 38 -22.42 A PRO 90 A PRO 90 17 A PRO 91 A PRO 91 7.62 A SER 37 A SER 37 18 A PRO 38 A PRO 38 -25.01 A PRO 90 A PRO 90 18 A PRO 91 A PRO 91 -1.10 A SER 37 A SER 37 19 A PRO 38 A PRO 38 -18.68 A PRO 90 A PRO 90 19 A PRO 91 A PRO 91 7.82 A SER 37 A SER 37 20 A PRO 38 A PRO 38 -22.13 A PRO 90 A PRO 90 20 A PRO 91 A PRO 91 5.84 A SER 37 A SER 37 21 A PRO 38 A PRO 38 -23.27 A PRO 90 A PRO 90 21 A PRO 91 A PRO 91 10.26 A SER 37 A SER 37 22 A PRO 38 A PRO 38 -19.80 A PRO 90 A PRO 90 22 A PRO 91 A PRO 91 4.86 A SER 37 A SER 37 23 A PRO 38 A PRO 38 -23.36 A PRO 90 A PRO 90 23 A PRO 91 A PRO 91 -4.78 A SER 37 A SER 37 24 A PRO 38 A PRO 38 -23.41 A PRO 90 A PRO 90 24 A PRO 91 A PRO 91 13.08 A SER 37 A SER 37 25 A PRO 38 A PRO 38 -21.04 A PRO 90 A PRO 90 25 A PRO 91 A PRO 91 12.97 A SER 37 A SER 37 26 A PRO 38 A PRO 38 -21.10 A PRO 90 A PRO 90 26 A PRO 91 A PRO 91 8.59 A SER 37 A SER 37 27 A PRO 38 A PRO 38 -21.59 A PRO 90 A PRO 90 27 A PRO 91 A PRO 91 -1.78 A SER 37 A SER 37 28 A PRO 38 A PRO 38 -24.62 A PRO 90 A PRO 90 28 A PRO 91 A PRO 91 10.71 A SER 37 A SER 37 29 A PRO 38 A PRO 38 -22.25 A PRO 90 A PRO 90 29 A PRO 91 A PRO 91 8.88 A SER 37 A SER 37 30 A PRO 38 A PRO 38 -22.03 A PRO 90 A PRO 90 30 A PRO 91 A PRO 91 -1.09 ANGI_HUMAN UNP 1 1 P03950 MVMGLGVLLLVFVLGLGLTPPTLAQDNSRYTHFLTQHYDAKPQGRDDRYCESIMRRRGLTSPCKDINTFIHGNKRSIKAI CENKNGNPHRENLRISKSSFQVTTCKLHGGSPWPPCQYRATAGFRNVVVACENGLPVHLDQSIFRRP 25 147 1AWZ 1 123 P03950 A 1 1 123 3 4 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A ILE 42 A ILE 42 A HIS 47 A HIS 47 A PHE 76 A PHE 76 A LEU 83 A LEU 83 A TYR 94 A TYR 94 A ARG 101 A ARG 101 A GLY 62 A GLY 62 A HIS 65 A HIS 65 A LEU 69 A LEU 69 A SER 72 A SER 72 A VAL 104 A VAL 104 A GLU 108 A GLU 108 A LEU 111 A LEU 111 A LEU 115 A LEU 115 RIBONUCLEOLYTIC ACTIVE SITE. Unknown 8 PUTATIVE CELL RECEPTOR BINDING SITE. Unknown 6 NUCLEOLAR LOCALIZATION SIGNAL. Unknown 3 A GLN 12 A GLN 12 8 1_555 A HIS 13 A HIS 13 8 1_555 A LYS 40 A LYS 40 8 1_555 A THR 44 A THR 44 8 1_555 A HIS 114 A HIS 114 8 1_555 A LEU 115 A LEU 115 8 1_555 A ASP 116 A ASP 116 8 1_555 A GLN 117 A GLN 117 8 1_555 A LYS 60 A LYS 60 6 1_555 A ASN 61 A ASN 61 6 1_555 A ARG 66 A ARG 66 6 1_555 A GLU 67 A GLU 67 6 1_555 A ASN 68 A ASN 68 6 1_555 A ASN 109 A ASN 109 6 1_555 A ARG 31 A ARG 31 3 1_555 A ARG 32 A ARG 32 3 1_555 A ARG 33 A ARG 33 3 1_555 1 P 1